Schaus JM

References (2)

Title : Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders - Bruns_2017_Neuropharmacol_128_351
Author(s) : Bruns RF , Mitchell SN , Wafford KA , Harper AJ , Shanks EA , Carter G , O'Neill MJ , Murray TK , Eastwood BJ , Schaus JM , Beck JP , Hao J , Witkin JM , Li X , Chernet E , Katner JS , Wang H , Ryder JW , Masquelin ME , Thompson LK , Love PL , Maren DL , Falcone JF , Menezes MM , Zhang L , Yang CR , Svensson KA
Ref : Neuropharmacology , 128 :351 , 2017
Abstract : Bruns_2017_Neuropharmacol_128_351
ESTHER : Bruns_2017_Neuropharmacol_128_351
PubMedSearch : Bruns_2017_Neuropharmacol_128_351
PubMedID: 29102759

Title : LY353433, a potent, orally effective, long-acting 5-HT(4) receptor antagonist: comparison to cisapride and RS23597-190 - Cohen_1996_J.Pharmacol.Exp.Ther_277_97
Author(s) : Cohen ML , Bloomquist W , Schaus JM , Thompson DC , Susemichel AD , Calligaro DA , Cohen I
Ref : Journal of Pharmacology & Experimental Therapeutics , 277 :97 , 1996
Abstract : Cohen_1996_J.Pharmacol.Exp.Ther_277_97
ESTHER : Cohen_1996_J.Pharmacol.Exp.Ther_277_97
PubMedSearch : Cohen_1996_J.Pharmacol.Exp.Ther_277_97
PubMedID: 8613972